GDTC

CytoMed Therapeutics Limited Ordinary Shares (GDTC)

US
$ 3.45-1.43%

Price Chart

Key Statistics

Market Cap
$ 25.39M
P/E Ratio
0.00
Revenue (TTM)
$ 503.37K
Volume
21.12K
52W High
$ 4.05
52W Low
$ 1.20
Dividend Yield
0.00%
Beta
-0.29

Technicals

50-Day MA
2.3642
200-Day MA
2.3037
52 Week High
4.0499
52 Week Low
1.2

About GDTC

CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia .

Employees
43
Headquarters
Singapore, Singapore
CEO
Mr. Chee Kong Choo

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
IMNN
Imunon Inc. Common ...
$ 1.26
203.25
OKLO
Oklo Inc.
$ 47.95
20.81
SMR
NuScale Power Corpo...
$ 29.75
17.50
ASPI
ASP Isotopes Inc. C...
$ 8.74
11.91
CCJ
Cameco Corporation ...
$ 58.80
11.34

Top Losers

Symbol/Name
LTP
% Chg
SYTA
Siyata Mobile Inc. ...
$ 5.64
-20.00
MNSO
MINISO Group Holdin...
$ 18.31
-17.49
NVTS
Navitas Semiconduct...
$ 4.43
-14.48
TPET
Trio Petroleum Corp...
$ 1.11
-13.28
WDAY
Workday Inc. Class ...
$ 238.20
-12.50